Urogen Pharma Ltd (URGN)

$13.91 0.09 (0.65%)
13:04 EDT URGN Stock Quote Delayed 30 Minutes

URGN Stock Earnings: UroGen Pharma Misses EPS, Beats Revenue for Q4 2023

URGN stock results show that UroGen Pharma missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.

7 Stocks to Buy for Their Double-Digit Growth Prospects

Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap 421.23M
PE Ratio -10.95
EPS -1.27
Volume (Avg. Vol.) 51,763
Day's Range $13.69 - $14.32
52-Week Range $8.69 - $24.13
Dividend & Yield N/A (N/A)